Email this article 
Post a Comment Analysis of results of cytological screening of cervix in persons living in Perm territory
- Authors: Schekotova A.P.1, Bulatova I.A.1, Paducheva S.V.1, Shabieva O.R.1, Pogrebnova L.S.1, Bezmaternykh S.P.1, Saprykina I.A.1
-
Affiliations:
- E.A. Vagner Perm State Medical University
- Issue: Vol 37, No 3 (2020)
- Pages: 66-74
- Section: Methods of diagnosis and technologies
- URL: https://ogarev-online.ru/PMJ/article/view/44256
- DOI: https://doi.org/10.17816/pmj37366-74
- ID: 44256
Cite item
Full Text
Abstract
Objective. To analyze the results of cytological screening for cervical cancer in women, living in the Perm Territory.
Materials and methods. The work is based on the results of a cytological study of 4670 women aged 29 to 70 years who underwent additional medical examinations in medical institutions of Perm and the Perm Territory for the period from 2017 to 2019.
Results. It was established that regardless of the place of residence, normal cytograms prevail. Inflammatory changes were more often observed in the urban population than among women living in the village. As age increased, the number of neoplastic changes in the cervix increased with a peak incidence at the age of 50. Detection of cervical cancer in the Perm Territory was 0.03 % that corresponds to the average statistical indicators in Russia, although this apparently reflects the problems of hypodiagnosis in cytological screening, since in the country in recent years the incidence of cervical cancer and mortality from it has been increasing.
Conclusions. The cytological method is a key step in cervical cancer screening, since it allows you to identify early pathological changes in case of adequate collection of material, correct staining of preparations, and a highly qualified cytologist.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
A. P. Schekotova
E.A. Vagner Perm State Medical University
Author for correspondence.
Email: al_shchekotova@mail.ru
MD, PhD, Professor, Department of Faculty Therapy №2, Professional Pathology and Clinical Laboratory Diagnostics
Russian Federation, PermI. A. Bulatova
E.A. Vagner Perm State Medical University
Email: al_shchekotova@mail.ru
MD, PhD, Professor, Department of Faculty Therapy №2, Professional Pathology and Clinical Laboratory Diagnostics
Russian Federation, PermS. V. Paducheva
E.A. Vagner Perm State Medical University
Email: al_shchekotova@mail.ru
Candidate of Medical Sciences, Head of Clinical Diagnostic Laboratory, City Clinical Hospital №2 named after F.Kh. Gral
Russian Federation, PermO. R. Shabieva
E.A. Vagner Perm State Medical University
Email: al_shchekotova@mail.ru
physician of Clinical Laboratory Diagnostics, City Clinical Hospital №4
Russian Federation, PermL. S. Pogrebnova
E.A. Vagner Perm State Medical University
Email: al_shchekotova@mail.ru
physician of Clinical Laboratory Diagnostics, Hospital №140, FMBA
Russian Federation, PermS. P. Bezmaternykh
E.A. Vagner Perm State Medical University
Email: al_shchekotova@mail.ru
physician of Clinical Laboratory Diagnostics, Perm Central Regional Hospital
Russian Federation, PermI. A. Saprykina
E.A. Vagner Perm State Medical University
Email: al_shchekotova@mail.ru
physician of Clinical Laboratory Diagnostics, City Clinical Hospital named after S.N. Grinberg
Russian Federation, PermReferences
- Glukhova Yu.K., Volchenko N.N. A draft program for a national cytological screening for cervical cancer. Clinical Cytology News in Russia 2018; 3–4: 22–30 (in Russian).
- Ferlay J., Soerjomataram I., Ervik M. et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer 2013.
- Bhatla N., Aoki D., Sharma D.N., Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynecol Obstet 2018; 143 (Suppl. 2): 22–36.
- Australian Institute of Health and Welfare. Cervical screening in Australia 2005–2006. Cancer series no. 41. Cat. no. CAN 36. Canberra: AIHW 2008.
- Lоrincz A.T. Screening for cervical cancer: new alternatives and research. Salud Publica Mix 2013; 45: 5376–5387.
- Sawaya G.F., Smith-McCune K., Kupermann M. Cervical Cancer Screening: More Choices in 2019. Jama 2019; 20: 2018–2019.
- Jin J. Screening for Cervical Cancer. Jama 2018; 7: 732.
- Sankaranarayanan R. Screening for cancer in low and middle income countries. Ann Glob Health 2014; 80: 412–417.
- The status of cancer care for the population of Russia in 2018. Ed. HELL. Kaprina, V.V. Starinskogo, G.V. Petrovoy. M.: MNII them. P.A. Herzen – a branch of the Federal State Budgetary Institution Scientific Research Center for Radiology of the Ministry of Health of Russia 2019; 236 (in Russian).
- Liquid and traditional cytology for diseases of the cervix. Cytological Atlas. Under. ed. I.P. Shabalova, K.T. Kasoyanu 4th edition, revised and supplemented. Moscow – Tver: Triad 2016; 320 (in Russian).
- Shchekotova A.P., Bulatova I.A., Nenasheva O.Yu. Cytological diagnosis of cervical pathology: guidelines. Perm: GBOU VPO PSMU named after Academician E.A. Wagner Ministry of Health of Russia. 2015; 35 (in Russian).
- Goryaeva A.E., Petrov Yu.A. Cervical Cancer Screening. International Journal of Applied and Basic Research 2018; 4: 171–175 (in Russian).
Supplementary files
